{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:43:34Z","timestamp":1790711014620,"version":"4.1.0"},"reference-count":44,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,7,25]]},"DOI":"10.1253\/circj.cj-18-1391","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T22:03:58Z","timestamp":1560981838000},"page":"1726-1736","source":"Crossref","is-referenced-by-count":31,"title":["Withaferin A Prevents Myocardial Ischemia\/Reperfusion Injury by Upregulating AMP-Activated Protein Kinase-Dependent B-Cell Lymphoma2 Signaling"],"prefix":"10.1253","volume":"83","author":[{"given":"Rui","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Physiology, Shanxi Medical University"},{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Bond","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Physiology, Shanxi Medical University"},{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine, Temple University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore A","family":"Christopher","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard L.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physiology, Shanxi Medical University"},{"name":"Department of Emergency Medicine, Thomas Jefferson University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Patel SB, Rao NJ, Hingorani LL. Safety assessment of Withania somnifera extract standardized for Withaferin A: Acute and sub-acute toxicity study. <i>J Ayurveda Integr Med<\/i> 2016; 7: 30\u201337.","DOI":"10.1016\/j.jaim.2015.08.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: An update. <i>Arch Toxicol<\/i> 2015; 89: 867\u2013882.","DOI":"10.1007\/s00204-015-1472-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hahm ER, Lee J, Singh SV. Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells. <i>Mol Carcinog<\/i> 2014; 53: 907\u2013916.","DOI":"10.1002\/mc.22050"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Liu X, Qi W, Cooke LS, Kithsiri Wijeratne EM, Xu YM, Marron MT, et al. An analog of withaferin A activates the MAPK and glutathione \u201cstress\u201d pathways and inhibits pancreatic cancer cell proliferation. <i>Cancer Invest<\/i> 2011; 29: 668\u2013675.","DOI":"10.3109\/07357907.2011.626478"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hahm ER, Lee J, Kim SH, Sehrawat A, Arlotti JA, Shiva SS, et al. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. <i>J Natl Cancer Inst<\/i> 2013; 105: 1111\u20131122.","DOI":"10.1093\/jnci\/djt153"},{"key":"6","unstructured":"6. Manoharan S, Panjamurthy K, Menon VP, Balakrishnan S, Alias LM. Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters. <i>Indian J Exp Biol<\/i> 2009; 47: 16\u201323."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Li W, Zhang C, Du H, Huang V, Sun B, Harris JP, et al. Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model. <i>Mol Carcinog<\/i> 2016; 55: 1739\u20131746.","DOI":"10.1002\/mc.22423"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stan SD, Hahm ER, Warin R, Singh SV. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. <i>Cancer Res<\/i> 2008; 68: 7661\u20137669.","DOI":"10.1158\/0008-5472.CAN-08-1510"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Munagala R, Kausar H, Munjal C, Gupta RC. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. <i>Carcinogenesis<\/i> 2011; 32: 1697\u20131705.","DOI":"10.1093\/carcin\/bgr192"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nagalingam A, Kuppusamy P, Singh SV, Sharma D, Saxena NK. Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. <i>Cancer Res<\/i> 2014; 74: 2617\u20132629.","DOI":"10.1158\/0008-5472.CAN-13-2081"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. <i>Life Sci<\/i> 2003; 74: 125\u2013132.","DOI":"10.1016\/j.lfs.2003.07.007"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sarbishegi M, Khajavi O, Arab MR. Withania coagulans extract induces cell apoptosis and inhibits COX-2 expression in a rat model of benign prostatic hyperplasia. <i>Nephrourol Mon<\/i> 2016; 8: e39284.","DOI":"10.5812\/numonthly.39284"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: A neglected therapeutic target. <i>J Clin Invest<\/i> 2013; 123: 92\u20131004.","DOI":"10.1172\/JCI62874"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Aaboud M, Aad G, Abbott B, Abdinov O, Abeloos B, Abidi SH, et al. Search for new phenomena using the invariant mass distribution of same-flavour opposite-sign dilepton pairs in events with missing transverse momentum in s=13 Tepp collisions with the ATLAS detector. <i>Eur Phys J C Part Fields<\/i> 2018; 78: 625.","DOI":"10.1140\/epjc\/s10052-018-6081-9"},{"key":"15","unstructured":"15. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. <i>Indian J Exp Biol<\/i> 1997; 35: 236\u2013239."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Prabu PC, Panchapakesan S, Raj CD. Acute and sub-acute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in Wistar rats. <i>Phytother Res<\/i> 2013; 27: 1169\u20131178.","DOI":"10.1002\/ptr.4854"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, et al. Role of apoptosis in reperfusion injury. <i>Cardiovasc Res<\/i> 2004; 61: 414\u2013426.","DOI":"10.1016\/j.cardiores.2003.12.023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. <i>J Biol Chem<\/i> 2003; 278: 28372\u201328377.","DOI":"10.1074\/jbc.M303521200"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang Y, Gao E, Tao L, Lau WB, Yuan Y, Goldstein BJ, et al. AMP-activated protein kinase deficiency enhances myocardial ischemia\/reperfusion injury but has minimal effect on the antioxidant\/antinitrative protection of adiponectin. <i>Circulation<\/i> 2009; 119: 835\u2013844.","DOI":"10.1161\/CIRCULATIONAHA.108.815043"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Woodall MC, Woodall BP, Gao E, Yuan A, Koch WJ. Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia\/reperfusion injury. <i>Circ Res<\/i> 2016; 119: 1116\u20131127.","DOI":"10.1161\/CIRCRESAHA.116.309538"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li R, et al. Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. <i>Am J Physiol Endocrinol Metab<\/i> 2010; 298: E663\u2013E670.","DOI":"10.1152\/ajpendo.00663.2009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wang Y, Ma XL, Lau WB. Cardiovascular adiponectin resistance: The critical role of adiponectin receptor modification. <i>Trends Endocrinol Metab<\/i> 2017; 28: 519\u2013530.","DOI":"10.1016\/j.tem.2017.03.004"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yu J, Deliu E, Zhang XQ, Hoffman NE, Carter RL, Grisanti LA, et al. Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55. <i>J Biol Chem<\/i> 2013; 288: 22481\u201322492.","DOI":"10.1074\/jbc.M113.456178"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, et al. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. <i>J Ayurveda Integr Med<\/i> 2012; 3: 111\u2013114.","DOI":"10.4103\/0975-9476.100168"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. <i>Int J Cancer<\/i> 2011; 129: 2744\u20132755.","DOI":"10.1002\/ijc.25938"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lee J, Sehrawat A, Singh SV. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. <i>Breast Cancer Res Treat<\/i> 2012; 136: 45\u201356.","DOI":"10.1007\/s10549-012-2239-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Elmore S. Apoptosis: A review of programmed cell death. <i>Toxicol Pathol<\/i> 2007; 35: 495\u2013516.","DOI":"10.1080\/01926230701320337"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. <i>Adv Hematol<\/i> 2012; 2012: 524308.","DOI":"10.1155\/2012\/524308"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Qi D, Young LH. AMPK: Energy sensor and survival mechanism in the ischemic heart. <i>Trends Endocrinol Metab<\/i> 2015; 26: 422\u2013429.","DOI":"10.1016\/j.tem.2015.05.010"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kong D, Zheng T, Zhang M, Wang D, Du S, Li X, et al. Static mechanical stress induces apoptosis in rat endplate chondrocytes through MAPK and mitochondria-dependent caspase activation signaling pathways. <i>PLoS One<\/i> 2013; 8: e69403.","DOI":"10.1371\/journal.pone.0069403"},{"key":"31","unstructured":"31. Shohat B, Gitter S, Abraham A, Lavie D. Antitumor activity of withaferin A (NSC-101088). <i>Cancer Chemother Rep<\/i> 1967; 51: 271\u2013276."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Vanden Berghe W, Sabbe L, Kaileh M, Haegeman G, Heyninck K. Molecular insight in the multifunctional activities of Withaferin A. <i>Biochem Pharmacol<\/i> 2012; 84: 1282\u20131291.","DOI":"10.1016\/j.bcp.2012.08.027"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ravindran R, Sharma N, Roy S, Thakur AR, Ganesh S, Kumar S, et al. Interaction studies of Withania somnifera\u2019s key metabolite withaferin A with different receptors assoociated with cardiovascular disease. <i>Curr Comput Aided Drug Des<\/i> 2015; 11: 212\u2013221.","DOI":"10.2174\/1573409912666151106115848"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Shah N, Kataria H, Kaul SC, Ishii T, Kaur G, Wadhwa R. Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: Combinational approach for enhanced differentiation. <i>Cancer Sci<\/i> 2009; 100: 1740\u20131747.","DOI":"10.1111\/j.1349-7006.2009.01236.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. <i>Nat Rev Cancer<\/i> 2002; 2: 277\u2013288.","DOI":"10.1038\/nrc776"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. <i>Nat Rev Cancer<\/i> 2002; 2: 647\u2013656.","DOI":"10.1038\/nrc883"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Garcia de Yebenes J, Yebenes J, Mena MA. Neurotrophic factors in neurodegenerative disorders: Model of Parkinson\u2019s disease. <i>Neurotox Res<\/i> 2000; 2: 115\u2013137.","DOI":"10.1007\/BF03033789"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Cao DJ, Gillette TG, Hill JA. Cardiomyocyte autophagy: Remodeling, repairing, and reconstructing the heart. <i>Curr Hypertens Rep<\/i> 2009; 11: 406\u2013411.","DOI":"10.1007\/s11906-009-0070-1"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Dhingra S, Sharma AK, Singla DK, Singal PK. p38 and ERK1\/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. <i>Am J Physiol Heart Circ Physiol<\/i> 2007; 293: H3524\u2013E3531.","DOI":"10.1152\/ajpheart.00919.2007"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Qin F, Shite J, Liang CS. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: Association with changes in MAPK pathways. <i>Am J Physiol Heart Circ Physiol<\/i> 2003; 285: H822\u2013H832.","DOI":"10.1152\/ajpheart.00015.2003"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Liu J, Mao W, Ding B, Liang CS. ERKs\/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. <i>Am J Physiol Heart Circ Physiol<\/i> 2008; 295: H1956\u2013H1965.","DOI":"10.1152\/ajpheart.00407.2008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. <i>Nat Cell Biol<\/i> 2011; 13: 1016\u20131023.","DOI":"10.1038\/ncb2329"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. <i>Diabetes<\/i> 2013; 62: 1270\u20131281.","DOI":"10.2337\/db12-0533"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, et al. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. <i>Am J Physiol Endocrinol Metab<\/i> 2015; 309: E275\u2013E282.","DOI":"10.1152\/ajpendo.00577.2014"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/8\/83_CJ-18-1391\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T03:17:18Z","timestamp":1564197438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/8\/83_CJ-18-1391\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-1391","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]}}}